The global micro-pumps market was surpassed at USD 1.7 billion in 2021 and is expected to hit around USD 6.9 billion by 2030, growing at a CAGR of 16.84% from 2022 to 2030.
Increasing demand for Point-Of-Care-Testing (POCT) kits, rising awareness of controlled drug delivery systems, increasing miniaturization of medical devices, and increase in the research and development of pharmaceutical companies, is expected to drive the market.
In the product segment, the mechanical micro-pumps segment dominated the market in 2021 is expected to serve as a key revenue-generating product owing to their extensive use in microfabrication technology and the rise in microfluidics research. Drug Delivery held a lucrative share in the application segment and is expected to grow substantially. The rising adoption of implanted drug delivery systems and medical devices, as well as the increasing research in the field of drug delivery, supported the growth of this segment. For instance, Sensile AG (A Subsidiary of Gerresheimer) Medical announced it had developed a wearable micro-pump for a European pharmaceutical company that is designed to treat Parkinson’s disease.
The onset of the pandemic positively affected the medical devices market by the end of 2020. The use of Micro-pumps in biomedical and pharmaceutical research for Covid-19 treatments increased. Individuals with chronic diseases required frequent monitoring of vital signs from time to time which led to the adoption of Point-Of-Care-Testing (POCT) kits. Even after the pandemic, there is a rise in adoption of POCT kits at hospital, clinics, homes and hence, they are expected to support the growth of the market.
Scope of The Report
|Market Size in 2021||USD 1.7 billion|
|Revenue Forecast by 2030||USD 6.9 billion|
|Growth rate from 2022 to 2030||CAGR of 16.84%|
|Forecast Period||2022 to 2030|
|Segmentation||Products, applications, end use
|Companies Covered||Bartels Mikrotechnik GmbH; Bürkert Fluid Control Systems; TOPS INDUSTRY & TECHNOLOGY CO., LTD.; The Lee Company; Xiamen AJK Technology Co.,Ltd.; Xavitech; ALLDOO Micropump; Servoflo Corporation; Dolomite Microfluidics(Backtrace Holdings Ltd.); TTp ventus; Arcmed Group (Halma)|
The mechanical micro-pumps segment led the market and accounted for revenue share of around 56.0% in 2021. The market is anticipated to witness growth over the forecast period. This can be attributed to the use of mechanical micro-pumps in the Micro-Electro-Mechanical Systems (MEMS). The MEMS is used in drug delivery system vehicles, these systems are very cheap, easy to be operated, capable of monitoring diseases, and providing rapid detection and delivering medicines.
Mechanical micro-Pumps consist of moving parts like micro-valve membranes or flaps and actuation. Non-mechanical micro-Pumps do not need physical actuation, like capillary micro-Pumps. Non-mechanical micro-Pumps have certain limitations such as the actuation mechanisms interfering with the pumping liquids and the use of only low conductivity fluids. The increasing biomedical application of mechanical micro Pumps such as ‘Lab On Chip’ (LOC), micro-total analysis systems, and POCT are expected to drive the growth of the market. Advanced biological sample processing, manipulation, and analysis are possible in miniature fluidic devices by using to lab-on-chip (LoC) technology.
Drug Delivery is identified as the largest segment in 2021, accounting for around 32.5% of the market share. This can be attributed to the increasing use of micro-pumps in implanted drug delivery systems. The in-vitro diagnostic segment is expected to increase rapidly as micro-Pumps are used for early disease detection, easier monitoring, and increased personalization in the case of in-vitro diagnostics. There are also various developments in wearable medical devices that use micro-Pumps for transporting micro-fluids. For instance, in March 2022, Medtronic launched its MiniMed 780 G systems in India. The system is a part of new Medtronic portfolio of insulin pumps with smartphone technology via Bluetooth connectivity.
Such researches on new techniques of drug delivery seeks to develop micro devices capable of delivering exact quantities of close to the treatment site as possible and at right time. These devices are incorporated with micro-pumps, silicon micro-machined needles or controlled-release propellants for drug delivery, storage, and dispensing. The rising awareness of controlled drug delivery system devices and increasing production of drug delivery devices is expected to demand more number of micro-pumps and thereby drive the market growth.
The biotechnological and pharmaceutical companies segment held the largest revenue share of 39.3% in 2021. These companies require micro-Pumps for infusion therapies, biomedical research, and research therapies including vaccines. According to the April 2021 report of the Congressional Budget Office, in 2019, the pharmaceutical industry spent USD 83 billion dollars on R & D. Also, the number of new drugs approval increased by 60% compared between the years 2010 to 2019. Hence, an increase in research and development has led to increased demand for micro-Pumps and thereby contributed to the market share of biotechnological and pharmaceutical companies. Hospitals and diagnostic centers are expected to surge the market growth over the forecast period as there is an increase in the use of micro-Pumps in point-of-care diagnosis and in devices used for blood transport and glucose monitoring devices used in diabetes patients.
An increase in Point-of-Care-Testing (POCT) has risen since the COVID-19 pandemic. An increase in funding and strategic initiatives by multiple sources, including the U.S. Department of Defense (DOD), the NIH, and NBIB has been taken. For instance, in October 2020, the National Institute of Biomedical Imaging and Bioengineering created the Point-of-Care-Technologies Research Network to drive the development of point-of-care diagnostic technologies. POCT has the potential for early disease diagnosis, treatment of noncommunicable diseases, easier monitoring, and increased personalization. Rapid, reliable, and low-cost diagnostic tools at point-of-care (PoC) are therefore in high demand.
North America domianted the micro-pumps market and held the largest revenue sahre of 49.4% in 2021. High purchasing power, strong government support for quality healthcare, the presence of high-quality infrastructure for clinical and laboratory research, and high adoption of technologically advanced products are a few of the reasons driving regional market progress. Furthermore, the rise of the regional market has been aided by increased government support for medical devices and their approvals in this region. Likewise, advantageous government initiatives to assist research and development in the relevant industry are increasing the usage of devices made with micro-pumps, enhancing the market's growth.
Asia Pacific is projected to be the fastest-growing market over the forecast period owing to its increasing quality healthcare infrastructure, competent workforce, increasing awareness of healthcare products, rise in point-of-care diagnostic centers, and rigourous research and development initiative. In 2017-18, India spent 0.7 percent of its GDP on research and development, compared to 2.1 percent in China, 0.8 percent in South Africa, 1.3 percent in Brazil, and 1.1 percent in Russia.